https://www.biospace.com/rocket-pharmaceuticals-announces-participation-at-the-bofa-securities-2020-health-care-conference
Rocket Pharmaceuticals Announces Participation at the BofA Securities 2020 Health Care Conference -...
May 5, 2020 - Rocket Pharmaceuticals, Inc. announces that Gaurav Shah, M.D., Chief Executive Officer and President of Rocket is scheduled to present on Wednesday, May 13,...
rocket pharmaceuticalsat the
https://www.businesswire.com/news/home/20240102584546/en/Rocket-Pharmaceuticals-to-Present-at-42nd-Annual-J.P.-Morgan-Healthcare-Conference
Rocket Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for r...
j p morganrocket pharmaceuticals
https://www.home.saxo/da-dk/markets/stocks/rckt-xnas
Rocket Pharmaceuticals Inc. aktie | Saxo
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company.
rocket pharmaceuticalsincaktiesaxo
https://theorg.com/org/rocket-pharmaceuticals?person=jonathan-schwartz
Rocket Pharmaceuticals | The Org
Bringing hope and relief to patients with undertreated rare diseases through the development and commercialization of curative first-in-class gene-modified...
rocket pharmaceuticals
https://www.biospace.com/press-releases/rocket-pharmaceuticals-to-participate-in-upcoming-september-2025-investor-conferences
Rocket Pharmaceuticals to Participate in Upcoming September 2025 Investor Conferences - BioSpace
rocket pharmaceuticalsto participateinvestor conferences
https://www.macrotrends.net/stocks/charts/RCKT/rocket-pharmaceuticals/number-of-employees
Rocket Pharmaceuticals Number of Employees 2013-2026 | RCKT | MacroTrends
Rocket Pharmaceuticals number of employees from 2013 to 2026. Number of employees can be defined as a measure of financial performance calculated as operating...
number of employeesrocket pharmaceuticalsrcktmacrotrends
https://finviz.com/quote?t=RCKT&ty=si&ta=1&p=d
RCKT - Rocket Pharmaceuticals Inc Short Interest
RCKT - Rocket Pharmaceuticals Inc - Stock screener for investors and traders, financial visualizations.
rocket pharmaceuticalsrcktincshortinterest
https://www.biospace.com/rocket-pharmaceuticals-to-participate-in-the-chardan-7th-annual-genetic-medicines-conference
Rocket Pharmaceuticals to Participate in the Chardan 7th Annual Genetic Medicines Conference -...
Sep 27, 2023 - Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) today announced that Gaurav Shah, M.D., Chief Executive Officer, is scheduled to participate in a fireside chat at...
rocket pharmaceuticalsto participatein the
https://www.annualreports.com/Company/rocket-pharmaceuticals-inc
Rocket Pharmaceuticals, Inc. - AnnualReports.com
rocket pharmaceuticalsinc
https://www.prnewswire.com/news-releases/rocket-pharmaceuticals-inc-sued-for-securities-law-violations--investors-should-contact-the-gross-law-firm-for-more-information--rckt-302520044.html
Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The...
/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). Shareholders who purchased...
rocket pharmaceuticalssecurities law
https://www.finanznachrichten.de/aktien-analysen/rocket-pharmaceuticals-inc.htm
ROCKET PHARMACEUTICALS-AKTIE kaufen? Analysen, Kursziele & Empfehlungen zu A2JA9Q
ROCKET PHARMACEUTICALS-Aktie jetzt kaufen? Analysen und Kursziele:
rocket pharmaceuticalsaktiekaufenanalysenkursziele
https://www.lawinsider.com/company/1281895/rocket-pharmaceuticals-inc
Rocket Pharmaceuticals, Inc. Sample Contracts | Law Insider
View Rocket Pharmaceuticals, Inc. contracts and agreements from SEC filings. Including company executives, business partners, clauses and more.
rocket pharmaceuticalssample contractsinclawinsider
https://www.prnewswire.com/news-releases/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302521515.html
Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities...
https://www.biospace.com/rocket-pharmaceuticals-receives-fda-fast-track-and-orphan-drug-designations-for-rp-a601-gene-therapy-for-pkp2-arrhythmogenic-cardiomyopathy-acm
Rocket Pharmaceuticals Receives FDA Fast Track and Orphan Drug Designations for RP-A601 Gene...
Jun 8, 2023 - Rocket Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track and Orphan Drug designations to RP-A601,...
https://www.careerbuilder.com/job-details/senior-vice-president-regulatory-affairs-cranbury-nj--ec701034-82ad-4021-b7c1-ff95ccd29bb8
Senior Vice President, Regulatory Affairs Job in Cranbury, New Jersey - Rocket Pharmaceuticals |...
Now hiring. Senior Vice President, Regulatory Affairs opening in Cranbury, New Jersey posted 30+ days ago by Rocket Pharmaceuticals. Apply today on...
senior vice presidentregulatory affairs
https://www.biospace.com/press-releases/rocket-pharmaceuticals-announces-new-england-journal-of-medicine-publication-of-phase-1-rp-a501-long-term-data-and-presents-at-late-breaking-scientific-sessions-at-2024-american-heart-association-conference
Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501...
new england journal